News
High PECAM-1 Levels in PAH May Predict Treprostinil Response
Results from a post hoc biomarker analysis of the FREEDOM-C2 study show high levels of platelet endothelial cell adhesion molecule 1 (PECAM-1) are associated with less improvement in 6-minute walk distance (6MWD) and may also be predictive of response to treprostinil therapy.
Source: Pulmonology Advisor